Ticker Details
MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.
IPO Date:	March 1, 2008
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$631.14M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 2.84%
Avg Daily Range (30 D):	$0.11 | 2.61%
Avg Daily Range (90 D):	$0.09 | 2.34%

Institutional Daily Volume
Avg Daily Volume:	.78M
Avg Daily Volume (30 D):	1.17M
Avg Daily Volume (90 D):	1.21M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	132
Avg Trade Size (Sh.) (90 D):	128

Institutional Trades
Total Institutional Trades:	2,214
Avg Institutional Trade:	$1.37M
Avg Institutional Trade (30 D):	$.76M
Avg Institutional Trade (90 D):	$1.02M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.44M
Avg Closing Trade (30 D):	$.78M
Avg Closing Trade (90 D):	$1M
Avg Closing Volume:	181.8K

News

Feb 17, 2026 @ 1:00 PM MIMEDX to Host Fourth Quarter and Full Year 2025 O... Source: Na

Feb 2, 2026 @ 1:00 PM MIMEDX Celebrates 15 Year Anniversary of EPIFIXÂÂ... Source: Mimedx Group, Inc.

Oct 15, 2025 @ 12:00 PM MIMEDX to Host Third Quarter 2025 Operating and Fi... Source: Matt Notarianni

Sep 3, 2025 @ 12:00 PM MIMEDX to Sponsor and Attend Symposium on Advanced... Source: Matt Notarianni

Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.1	$-.07
Diluted EPS	$-.1	$-.07
Revenue	$64.36M	$58.99M
Gross Profit	$44.38M	$41.62M
Net Income / Loss	$-14.84M	$-10.86M
Operating Income / Loss	$-18.47M	$-16.05M
Cost of Revenue	$19.98M	$17.37M
Net Cash Flow	$-23.93M	$-6.35M
PE Ratio

Splits
Apr 02, 2008	11:34